Clinical Trials Browser

Phase 3 × Lymphoma, B-Cell × Drug Therapy × Clear all

NCT03570892 2026-01-06

BELINDA

Phase 3 Active not recruiting

331 enrolled 10 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse